Ads
-
Related paper
- Exploring molecular docking and electronic studies of [11C]LY2795050 as a novel antagonist tracer for positron emission tomography (PET) scan of the kappa (κ) and mu (µ) opioid receptors (KOR and MOR)
- Docking and molecular dynamics simulations studies of human protein kinase catalytic subunit alpha with antagonist
- IN SILICO MOLECULAR DOCKING AND ADME/T STUDIES OF SELECTED COMPOUNDS OF SWERTIA CHIRATA (GENTIANACEAE) AGAINST TWO RECEPTORS OF TYPE 2 DIABETES
- The Role of Positron-Emission Tomography/Computed Tomography in Patients with Colorectal Liver Metastases who are Candidates for Liver Resection: Is it Useful?
- YIELDS CALCULATIONS FOR POSITRON EMISSION TOMOGRAPHY (PET) FOR NON-STANDARD RADIONUCLIDE
- Evaluation of Dopamine Receptor Integrity after Sevofl urane Exposure in Neonatal Rat Brain Using Positron Emission Tomography
- Simvastatin and Recombinant Antagonist of Receptors of Interleukin-1 Modulate Aryl Hydrocarbon Receptors in Experimental Colitis in Rats
- Synthesis of Silver Nanoparticles from Bauhinia acuminata Aqueous Leaf Extract and Molecular Docking Analysis of Various Cancer Receptors
- Structural Properties Study and Spectroscopic (FT-IR and UV-Vis) Profiling of the Novel Antagonist LY2157299 as a Transforming Growth Factor-β (TGF-β) Receptor I Kinase Inhibitor by Quantum-mechanical (QM) and Molecular Docking Techniques
- Molecular Spectroscopy and Molecular Docking Studies on (E)-1-(4-Bromobenzylidene) Thiourea